Biotest AG
BIESF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $26,400 | $127,000 | $31,700 | -$63,400 |
| Dep. & Amort. | $40,600 | $35,900 | $35,800 | $31,100 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$200 | -$168,500 | -$45,200 | $21,500 |
| Other Non-Cash | -$5,900 | $2,900 | -$62,800 | $44,700 |
| Operating Cash Flow | $60,900 | -$2,700 | -$40,500 | $33,900 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$28,700 | -$33,400 | -$29,300 | -$18,200 |
| Net Acquisitions | $0 | $35,000 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,000 | -$300 | -$7,700 | -$5,200 |
| Investing Cash Flow | -$25,700 | $1,300 | -$37,000 | -$23,400 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$27,700 | -$8,900 | $100,000 | $19,800 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1,600 | $0 | -$800 | -$800 |
| Other Fin. Act. | -$6,100 | $2,100 | -$9,600 | $3,600 |
| Financing Cash Flow | -$35,400 | -$6,800 | $89,600 | $22,600 |
| Forex Effect | -$100 | $100 | $100 | $0 |
| Net Chg. in Cash | -$300 | -$8,500 | $12,200 | $33,100 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $108,100 | $116,600 | $104,400 | $71,300 |
| End Cash | $107,800 | $108,100 | $116,600 | $104,400 |
| Free Cash Flow | $32,200 | -$36,100 | -$69,800 | $15,700 |